Yu-fen Tsai

Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma.

RAD51 is a poor prognostic marker and a potential therapeutic target for oral squamous cell carcinoma.

Journal: Cancer cell international

Published: March 25, 2023

Decreased Circulating Melatonin with Loss of Age-Related Biphasic Change in Patients with Oral Squamous Cell Carcinoma.

Decreased Circulating Melatonin with Loss of Age-Related Biphasic Change in Patients with Oral Squamous Cell Carcinoma.

Journal: Journal of personalized medicine

Published: October 19, 2021

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.

Poor Prognosis of Diffuse Large B-Cell Lymphoma with Hepatitis C Infection.

Journal: Journal of personalized medicine

Published: July 09, 2021

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study.

A Novel Combination of Bevacizumab with Chemotherapy Improves Therapeutic Effects for Advanced Biliary Tract Cancer: A Retrospective, Observational Study.

Journal: Cancers

Published: June 26, 2021

Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study.

Metronomic vinorelbine is an excellent and safe treatment for advanced breast cancer: a retrospective, observational study.

Journal: Journal of Cancer

Published: March 20, 2021

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment.

Management of Hepatitis B Virus Reactivation in Malignant Lymphoma Prior to Immunosuppressive Treatment.

Journal: Journal of personalized medicine

Published: March 18, 2021

Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.

Comment on: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis.

Journal: The British journal of surgery

Published: January 06, 2021

S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis.

S1 versus Doublet Regimens as Adjuvant Chemotherapy in Patients with Advanced Gastric Cancer after Radical Surgery with D2 Dissection-A Propensity Score Matching Analysis.

Journal: Cancers

Published: July 01, 2020

Comet tail, an indicator for DNA damage or repair?: Refers to Liu et al. Oral Oncology 2020 Jan;100:104469.

Comet tail, an indicator for DNA damage or repair?: Refers to Liu et al. Oral Oncology 2020 Jan;100:104469.

Journal: Oral oncology

Published: February 26, 2020

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study.

Rituximab increases the risk of hepatitis B virus reactivation in non-Hodgkin lymphoma patients who are hepatitis B surface antigen-positive or have resolved hepatitis B virus infection in a real-world setting: a retrospective study.

Journal: PeerJ

Published: March 26, 2019

Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan.

Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan.

Journal: Medicine

Published: June 29, 2018

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma

Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology

Published: February 11, 2017

Showing 1-12 of 18

Last Updated: 09/26/2026